Biotech · Private company
Diakonos Oncology Corporation
Track this companyFree. Adds Diakonos Oncology Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- DOC1021Phase 2 · Glioblastoma (GBM)ClinicalTrials.gov · fetched Nov 12, 2026
- DOC1021Phase 2 · Refractory MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- pIFN (peginterferon alfa-2a)Phase 2 · Refractory MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- SOC cranial radiationPhase 2 · Glioblastoma (GBM)ClinicalTrials.gov · fetched Nov 12, 2026
- Temodar (Temozolomide)Phase 2 · Glioblastoma (GBM)ClinicalTrials.gov · fetched Nov 12, 2026
- Tumor resectionPhase 2 · Refractory MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Tumor resectionPhase 2 · Glioblastoma (GBM)ClinicalTrials.gov · fetched Nov 12, 2026
- Autologous DC TherapyPhase 1 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- DOC1021 Dendritic Cell Immunotherapy for Refractory MelanomaPHASE1_PHASE2 · RECRUITING · started Apr 6, 2026ClinicalTrials.gov NCT07288112 · fetched Nov 12, 2026
- DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)PHASE2 · RECRUITING · started Mar 17, 2025ClinicalTrials.gov NCT06805305 · fetched Nov 12, 2026
- Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic AdenocarcinomaPHASE1 · RECRUITING · started Aug 3, 2020ClinicalTrials.gov NCT04157127 · fetched Nov 12, 2026